Massachusetts General Hospital, Boston, Massachusetts.
Abiomed, Danvers, Massachusetts.
Catheter Cardiovasc Interv. 2021 Jan 1;97(1):74-77. doi: 10.1002/ccd.28677. Epub 2019 Dec 26.
The aim is to evaluate the feasibility of using mechanical circulatory support, specifically the Impella device, in spontaneous coronary artery dissection (SCAD) patients with cardiogenic shock.
The therapeutic options for managing SCAD complicated by cardiogenic shock are limited. Risky revascularization procedures are often necessary.
This was a multicenter case series in the United States. Approximately 20 cases of Impella implantation in patients with SCAD are known. The implanting physician for each of these cases was contacted and de-identified records were requested. The records were analyzed for Impella indications, outcomes, and complications.
Records from four cases were received. All patients survived to hospital discharge and no major complications were observed. In two cases, cardiogenic shock developed in the absence of ongoing ischemia, suggesting a Takotsubo-like cardiomyopathy. In these cases, the Impella provided hemodynamic support until the patient's cardiac function recovered.
Although a small case series, given the scarcity of SCAD cases complicated by cardiogenic shock and the limited therapies available to treat these patients, these data are of clinical value in highlighting the feasibility of Impella use in SCAD. The Impella can be valuable for procedural support and in cardiogenic shock, especially in cases without evidence of ongoing ischemia.
评估使用机械循环支持,特别是 Impella 装置,治疗自发性冠状动脉夹层(SCAD)并发心原性休克患者的可行性。
管理 SCAD 并发心原性休克的治疗选择有限。通常需要进行风险较大的血运重建手术。
这是美国的一项多中心病例系列研究。已知大约有 20 例 SCAD 患者接受了 Impella 植入术。联系了每位患者的植入医生,并请求提供去标识化的病历。对病历进行了分析,以了解 Impella 的适应证、结局和并发症。
收到了 4 例病例的记录。所有患者均存活至出院,未观察到重大并发症。在 2 例患者中,心原性休克发生在没有持续缺血的情况下,提示 Takotsubo 样心肌病。在这些病例中,Impella 提供了血流动力学支持,直到患者的心脏功能恢复。
尽管这是一个小的病例系列,但鉴于 SCAD 并发心原性休克的病例稀少,且治疗这些患者的可用疗法有限,这些数据在强调 Impella 在 SCAD 中的应用可行性方面具有临床价值。Impella 在程序支持和心原性休克中都很有价值,尤其是在没有证据表明持续缺血的情况下。